002750.SZ

Kunming Longjin Pharmaceutical Co., Ltd. [002750.SZ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

002750.SZ Stock Summary

Top 002750.SZ Correlated Resources

002750.SZ


Top 10 Correlated ETFs

002750.SZ


Top 10 Correlated Stocks

002750.SZ


002750.SZ Financial details

Company Rating
Buy
Market Cap
5.31B
Income
-1.62M
Revenue
299.05M
Book val./share
1.6
Cash/share
1.05
Dividend
-
Dividend %
-
Employees
517
Optionable
No
Shortable
Yes
Earnings
29 Apr 2022
P/E
-3249.12
Forward P/E
-
PEG
285.14
P/S
17.57
P/B
8.27
P/C
12.63
P/FCF
-173.85
Quick Ratio
4.17
Current Ratio
5.05
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-73.9%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-38.54%
Revenue last 5Y
18.2%
Revenue Q/Q
-19.24%
EPS Q/Q
-74.22%
-
-
-
-
SMA20
16.67%
SMA50
40%
SMA100
16.67%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-0.01%
Gross Margin
47%
Oper. Margin
-2%
Profit Margin
-1%
Payout
-
Shs Outstand
400.5M
Shs Float
156.89M
-
-
-
-
Target Price
-
52W Range
7.16-24.33
52W High
-44.75%
52W Low
+89.43%
RSI
48
Rel Volume
0.55
Avg Volume
33.57M
Volume
18.6M
Perf Week
0.38%
Perf Month
19.14%
Perf Quarter
11.34%
Perf Half Y
17.87%
-
-
-
-
Beta
0.488454
-
-
Volatility
0.27%, 1.82%
Prev Close
0.84%
Price
13.26
Change
-4.05%

002750.SZ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
0.760.840.690.631.75
Net income per share
0.090.03-0.060.030.01
Operating cash flow per share
0.140.080.01-0.02-0.04
Free cash flow per share
0.10.04-0.01-0.08-0.06
Cash per share
0.180.961.011.031.07
Book value per share
1.611.611.561.591.59
Tangible book value per share
1.571.561.531.641.57
Share holders equity per share
1.611.611.561.591.59
Interest debt per share
00.03000
Market cap
3.64B2.26B4.97B3.28B5.2B
Enterprise value
3.57B1.87B4.77B3.16B5.1B
P/E ratio
103.53162.72-214.9277.631.68K
Price to sales ratio
11.966.7218.0412.917.41
POCF ratio
62.771.21.23K-483.88-351.42
PFCF ratio
89.84139.6-1.64K-107.92-206.82
P/B Ratio
5.643.497.965.168.14
PTB ratio
5.643.497.965.168.14
EV to sales
11.725.5717.3312.427.26
Enterprise value over EBITDA
55.9638.371.03K79.61140.57
EV to operating cash flow
61.4859.081.18K-465.59-344.62
EV to free cash flow
88.09115.83-1.57K-103.84-202.81
Earnings yield
0.010.01000
Free cash flow yield
0.010.010-0.010
Debt to equity
00000
Debt to assets
0.180.170.170.160.18
Net debt to EBITDA
-1.11-7.87-42.15-3.13-2.78
Current ratio
4.284.754.565.184.61
Interest coverage
39.140.3900-11.64
Income quality
1.652.29-0.17-0.57-4.79
Dividend Yield
0.020.01000
Payout ratio
1.710.87000.13
Sales general and administrative to revenue
0.030.030.030.030.01
Research and developement to revenue
0.090.10.080.080.03
Intangibles to total assets
0.020.040.060.060.06
Capex to operating cash flow
-0.3-0.49-1.753.480.7
Capex to revenue
-0.06-0.05-0.03-0.09-0.01
Capex to depreciation
-0.79-0.68-0.27-0.84-0.34
Stock based compensation to revenue
00000
Graham number
1.781.121.421.030.53
ROIC
0.050.0100.01-0.01
Return on tangible assets
0.050.02-0.030.010
Graham Net
-0.130.660.70.750.74
Working capital
366.79M373.13M374.23M419.33M409.37M
Tangible asset value
627.16M624.91M613.72M655.95M629.21M
Net current asset value
338.98M340.95M338.48M382.56M373.78M
Invested capital
00000
Average receivables
00000
Average payables
11.03M15.13M14.63M15.28M13.55M
Average inventory
42.27M40.93M45.19M54.67M43.79M
Days sales outstanding
00000
Days payables outstanding
72.79164.98105.8108.68.91
Days of inventory on hand
320.57299.36270.1388.6124.8
Receivables turnover
00000
Payables turnover
5.012.213.453.3640.95
Inventory turnover
1.141.221.350.9414.72
ROE
0.050.02-0.040.020
Capex per share
-0.04-0.04-0.02-0.06-0.03

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-06-302021-09-302022-03-312022-06-30 2022-09-30
Revenue per share
0.480.490.120.080.06
Net income per share
0.0100-0.010
Operating cash flow per share
00000
Free cash flow per share
0.010.01-0.03-0.03-0.03
Cash per share
1.041.071.061.031.05
Book value per share
1.61.611.611.611.6
Tangible book value per share
1.681.681.591.911.57
Share holders equity per share
1.61.611.611.611.6
Interest debt per share
0.030.03000
Market cap
3B2.87B6.7B4.73B3.94B
Enterprise value
2.9B2.78B6.61B4.61B3.86B
P/E ratio
335.27422.392.01K-358.3-1.16K
Price to sales ratio
15.6714.63140.81154.79159.54
POCF ratio
00000
PFCF ratio
1.03K586.89-570.36-354.87-391.4
P/B Ratio
4.684.4710.477.436.19
PTB ratio
4.684.4710.477.436.19
EV to sales
15.1514.14139.01151.02156.34
Enterprise value over EBITDA
1.98K952.714.02K-2.65K-20.71K
EV to operating cash flow
00000
EV to free cash flow
998.96567.22-563.04-346.22-383.55
Earnings yield
00000
Free cash flow yield
00000
Debt to equity
00000
Debt to assets
0.30.310.1700.17
Net debt to EBITDA
-67.76-33.03-52.3266.17423.76
Current ratio
2.612.575.045.225.05
Interest coverage
0-0.9712.85-21.8-13.56
Income quality
00000
Dividend Yield
00000
Payout ratio
00.2000
Sales general and administrative to revenue
-0.010.10.13-0.060.64
Research and developement to revenue
0.010.020.080.210.19
Intangibles to total assets
0.050.050.060.060.06
Capex to operating cash flow
00000
Capex to revenue
-0.02-0.01-0.03-0.18-0.52
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0.450.390.280.550.28
ROIC
000-0.01-0.01
Return on tangible assets
00000
Graham Net
0.430.430.761.090.77
Working capital
438.32M447.75M415.26M412.68M404.03M
Tangible asset value
669.4M671.24M630.41M0620.47M
Net current asset value
399.36M408.92M379.81M0370.65M
Invested capital
0.020.02000
Average receivables
00000
Average payables
88.53M95.5M13.74M14.63M13.33M
Average inventory
86.99M89.91M39.01M42.31M44.22M
Days sales outstanding
00000
Days payables outstanding
110.6113.44121.57317.61238.27
Days of inventory on hand
89.6788.46338.11918.21913.74
Receivables turnover
00000
Payables turnover
0.810.790.740.280.38
Inventory turnover
11.020.270.10.1
ROE
000-0.010
Capex per share
-0.01-0.010-0.01-0.03

002750.SZ Frequently Asked Questions

What is Kunming Longjin Pharmaceutical Co., Ltd. stock symbol ?

Kunming Longjin Pharmaceutical Co., Ltd. is a CN stock and trading under the symbol 002750.SZ

What is Kunming Longjin Pharmaceutical Co., Ltd. stock quote today ?

Kunming Longjin Pharmaceutical Co., Ltd. stock price is $13.26 today.

Is Kunming Longjin Pharmaceutical Co., Ltd. stock public?

Yes, Kunming Longjin Pharmaceutical Co., Ltd. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap